From Intake to Evidence:

Elmiron Eye Injury Litigation

How forward-thinking technology can help firms build stronger case inventories


About the Webinar

Widely prescribed over decades to treat a bladder condition called interstitial cystitis, Elmiron is now linked to maculopathy and other life-altering eye injuries. It is estimated that hundreds of thousands of people have taken the drug -- the majority of whom are women.  

As firms across the country work to sign Elmiron clients, SimplyConvert and Pattern Data are teaming up for a 45-minute webinar on Thursday, April 29th at 2 pm ET that you won't want to miss. 

From Intake to Evidence: Elmiron Eye Injury Litigation will include insights on the litigation from leading members of the Plaintiff's Steering Committee and will spotlight how firms can use forward-thinking technology to build stronger case inventories.

February 19, 2021 1 PM EST (2)Panelists will discuss the following: 

  • Elmiron litigation update and next steps
  • Science overview and injury profiles
  • Using AI to analyze medical data and identify case trends sooner
  • AI-powered client intake and evidence-driven refinements to case selection criteria

Space is limited. Register today!

Register Now

Complete the form below to register for the webinar, From Intake to Evidence: Elmiron Eye Injury Litigation.